Robert Alexander Joins Alta Partners as Principal
November 07, 2005
Firm Expands Clinical and Operational Expertise
San Francisco, CA., November 7, 2005 – Alta Partners, a life sciences and information technology
venture capital firm based in San Francisco, today announced that Robert Alexander had joined the
firm as a Principal. Alexander brings over a decade of life sciences investment, operations and
“Robert’s technical knowledge, as well as his business development and life sciences investing expertise are a great fit for our team,” said Dan Janney, Managing Director at Alta Partners. “He will bring significant value to our investing process and to our portfolio across the spectrum, from early to later stage opportunities.”
Prior to Alta, Robert was a Principal in MPM Capital's BioEquities fund where he sourced opportunities and led due diligence efforts for both public and private investments. Robert joined MPM from Genentech where he spent over three years in Business Development. At Genentech, his responsibilities included sourcing and screening product opportunities based on scientific merit and strategic fit, leading diligence teams and negotiating terms and definitive agreements. Prior to joining Genentech, Robert was a post-doctoral fellow at Stanford University in the department of Pathology. He holds a Ph.D. in Immunology from the University of North Carolina and a B.A. degree in Zoology from Miami University of Ohio.
About Alta Partners
Alta Partners is a diversified venture capital firm focused on life science and information technology investments. Headquartered in San Francisco, Alta currently manages seven funds aggregating over $1.5 billion in committed capital. Since its founding in 1996, Alta has been one of the most active life science investors funding over one hundred compto later-stage opportunities.